Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma

Medical Oncology

Volumn 29, Issue 1, 2012, Pages 151-160

  Lv, Jin ^a   Cao, Xiu Feng ^a   Ji, Lv ^a   Zhu, Bin ^a   Wang, Dong Dong ^a   Tao, Lei ^a   Li, Su Qing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

catenin; Bmi 1; Clinical pathology; Esophageal squamous cell carcinoma; Hoxa9; Immunohistochemistry; Prognosis; RT PCR; Smad4; Wnt 1

Indexed keywords

BETA CATENIN; BMI1 PROTEIN; MESSENGER RNA; SMAD4 PROTEIN; TRANSCRIPTION FACTOR HOXA9; WNT1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RNA, MESSENGER; SMAD4 PROTEIN; TUMOR MARKERS, BIOLOGICAL; WNT1 PROTEIN;

EID: 84864061537     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9816-5     Document Type: Article

References (31)

1. Piero Marco Fisichella and Marco G Patti. Esophageal Cancer. eMedicine: Oncology, Aug 26, 2008-08-26. http://emedicine.meds cape.com/article/277930- overview
2. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 6th ed. New York: Springer; 2002. p. 91-8.
3. James RG, Conrad WH, Moon RT. Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors. Methods Mol Biol. 2008;468:131-44.
4. Corrigan PM, Dobbin E, Freeburn RW, et al. Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. Stem Cells Dev. 2009;18:759-72.
5. Fillmore RA, Mitra A, Xi Y, et al. Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int J Cancer. 2009;125:556-64.
6. Matsubayashi S, Nakashima M, Kumagai K, et al. Immunohis-tochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Pathol Res Pract. 2009;205:626-33.
7. Clifford RL, Deacon K, Knox AJ. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, and GSK3 (beta). J Biol Chem. 2008;283:35337-53.
8. Tian X, Du H, Fu X, Li K, et al. Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells. Biochem Biophys Res Commun. 2009;380:478-83.
9. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov. 2006;5:997-1014. (Pubitemid 44835127)
10. Dihlmann S, von Knebel Doeberitz M. Wnt/-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int J Cancer. 2005;113:515-24. (Pubitemid 40038726)
11. Huang M, Wang Y, Sun D, et al. Identification of genes regulated by Wnt/b-catenin pathway and involved in apoptosis via micro-array analysis. BMC Cancer. 2006;6:221.
12. Winkel A, Stricker S, Tylzanowski P, et al. Wnt-ligand-depen-dent interaction of TAK1 (TGF-beta-activated kinase-1) with the receptor tyrosine kinase Ror2 modulates canonical Wnt-signal-ling. Cell Signal. 2008;20:2134-44.
13. Verkaar F, van Rosmalen JW, Smits JF, et al. Stably overex-pressed human Frizzled-2 signals through the beta-catenin pathway and does not activate Ca2?-mobilization in Human Embryonic Kidney 293 cells. Cell Signal. 2009;21:22-33.
14. Lyu J, Yamamoto V, Lu W. Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell. 2008;15:773-80.
15. Katoh M, Katoh M. WNT signaling pathway and stem cell signaling network. Clin Cancer Res. 2007;13:4042-5. (Pubitemid 47105963)
16. Paul S, Dey A. Wnt signaling and cancer development: therapeutic implication. Nat Rev Genet. 2008;55:165-76.
17. Herbst A, Kolligs FT. Wnt signaling as a therapeutic target for cancer. Methods Mol Biol. 2007;361:63-91. (Pubitemid 350183202)
18. Mizushima T, Nakagawa H, Kamberov YG, et al. Wnt-1 but not epidermal growth factor induces b-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res. 2002; 62:277-82. (Pubitemid 34074015)
19. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M, et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (Lond). 1999;397:164-8. (Pubitemid 29050921)
20. Nakanishi Y, Ochiai A, Akimoto S, et al. Expression of E-cad-herin, apha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology. 1997;54:158-65. (Pubitemid 27101765)
21. Krishnadath KK, Tilanus HW, Blankenstein MV, et al. Reduced expression of the cadherin\catenin complex in oesophageal ade-nocarcinoma correlates with poor prognosis. J Pathol. 1997;2:331-8. (Pubitemid 27285787)
22. Osterheld MC, Bian YS, Bosman FT, et al. Beta\catenin expression and its association with prognostic factors in adeno-carcinoma developed in Brrett esophagus. Am J Clin Pathol. 2002; 117:451-6. (Pubitemid 34226082)
23. Yanagiswa J, Yanagi Y, Masuhire Y. Convergenece of transforming growth factor-p and vitamin D signaling pathways on SMAD transcriptional coactivators. Science. 1999;283:l3l7-21.
24. Fukuchi M, Masuda N, Miyazaki T, et al. Decreased Smad4 expression in the transforming growth factor-b signaling pathway during progression of esophageal squamous cell carcinoma. Cancer. 2002;95:737-43. (Pubitemid 34839664)
25. Takahashi O, Hamada J-I, Abe M, et al. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncology Reports. 2007;17:753-60.
26. Cillo C, Barba P, Freschi G, et al. HOX gene expression in normal and neoplastichuman kidney. Int J Cancer. 1992;51: 892-7.
27. De Vita G, Barba P, Odartchenko N, et al. Expressionof homeobox-containing genes in primary and metastaticcolorectal cancer. Eur J Cancer. 1993;29A:887-93. (Pubitemid 23083624)
28. Cantile M, Cindolo L, Napodano G, et al. Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene. 2003;22:6462-8. (Pubitemid 37281694)
29. Waltregny D, Alami Y, Clausse N, et al. Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate. 2002;50:162-9. (Pubitemid 34137443)
30. Hamada J, Omatsu T, Okada F, et al. Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer. 2001;93:516-25. (Pubitemid 32701410)
31. Maeda K, Hamada J, Takahashi Y, et al. Altered expressions of HOX genes in human cutaneous malignant melanoma. Int J Cancer. 2005;114:436-41. (Pubitemid 40279966)